Biomarker test tracking is changing the dynamics of the oncology market, and monitoring it is key for pharma to understand product uptake and performance.
Miami, FL (October 26, 2016) Medimix International recently conducted an international survey among 1,032 oncologists in 21 non-English native countries (Europe, Asia, Americas, Africa Middle [...]
Increasing Launch Success: Medimix's New Syndicated Trackers The pharmaceutical market continues to evolve rapidly with a record year of drug introductions and an acceleration of [...]
Innovative Methodologies in Action. How to make biosimilars better? When Neil Armstrong set his foot on the moon 45 years ago, neither NASA nor any [...]
When facing large scale budgetary decisions for their commercial operations, most top executives rely on carrying forward what was historically considered important and on fresh [...]